|
Match
|
Document |
Document Title |
|
|
US20090306032 |
Use of solid lipid nanoparticles Comprising Cholesteryl Propionate and/or Cholesteryl Butyrate
The present invention refers to the use of solid lipid nanoparticles (SLN) obtained from warm microemulsions, containing cholesteryl propionate and/or cholesteryl butyrate, for preparation of a...
|
|
|
US20090306030 |
Methods Of Inhibiting Osteoclast Activity
Methods of inhibiting osteoclastogenesis and the activity of osteoclasts are disclosed. Methods of treating patients who have diseases characterized bone loss are disclosed. According to the...
|
|
|
US20090297576 |
Local Delivery of PAR-1 Antagonists to Treat Vascular Complications
Described herein are methods and medical devices used to deliver bioactive agents locally to patients in need of treatment and/or prevention of cardiovascular conditions Local delivery of...
|
|
|
US20090297477 |
Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders
The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, including post-partum auto immune diseases) and more particularly. Most preferably...
|
|
|
US20090291933 |
SOLID STATE FORMS OF A PHARMACEUTICAL
The invention provides and describes solid state 17α-ethynyl-androst-5-ene-3β,7β,17β-triol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and...
|
|
|
US20090291932 |
PHARMACEUTICAL SOLID STATE FORMS
The invention provides and describes solid state 17α-ethynyl-5α-androstane-3α,17β-diol including amorphous and crystalline forms and specific polymorphic forms thereof. Anhydrates and solvates...
|
|
|
US20090291931 |
COMPOSITIONS WITH ENHANCED ELASTICIZING ACTIVITY
Compositions for improving the elasticity of the vagina and of the perineum during the last trimester of pregnancy, include combining a thiolated compound or mixture thereof with an ester of...
|
|
|
US20090291920 |
DETECTION OF STEROID RECEPTORS ON CIRCULATING CARCINOMA CELLS AND TREATMENT
The expression of a steroid receptor from circulating carcinoma cells in a blood sample is detected by isolating the carcinoma cells from the blood sample, making an extract from the isolated...
|
|
|
US20090281071 |
THERAPEUTIC AGENT FOR HYPERTENSION
The present invention provides a novel hypertension therapeutic agent. The hypertension therapeutic agent of the present invention contains, as an active ingredient, a compound represented by...
|
|
|
US20090281070 |
Method for Preparing a Solid Pharmaceutical Composition with Sustained and Controlled Release by High Pressure Treatment
The invention concerns a method for preparing a unit-dose of a solid pharmaceutical composition with prolonged and controlled release by high pressure treatment of a solid composition comprising at...
|
|
|
US20090275545 |
Medicinal targeted local lipolysis
Aqueous phospholipid systems comprising at least one phospholipid, at least one bile acid and water are suitable for producing medicaments for the treatment of adipose tissue disorders and lead to...
|
|
|
US20090275544 |
Method and kit for reducing the symptoms of peripheral vascular disease
A method for reducing the symptoms of peripheral vascular disease and for improving peripheral circulation wherein a progestin is administered to a subject in need thereof.
|
|
|
US20090274757 |
PHARMACEUTICAL POLISH FORMULATIONS
Polish compositions for coating pharmaceutical solid dosage forms such as tablets are disclosed. The polish composition comprises water, coating agent, and a film forming agent. Polished...
|
|
|
US20090274741 |
POLYMERS CONTAINING POLY(ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME
Polymers containing poly(ester amides) and agents for use with medical articles and methods of fabricating the same are disclosed. The medical article generally comprises an implantable substrate...
|
|
|
US20090264387 |
ESTRA-1,3,5(10)-TRIENE DERIVATIVES FOR CONTRACEPTION
The invention relates to pharmaceutical compositions and administration forms, which contain compounds of the general formula (I)
and methods for contraception by administering these...
|
|
|
US20090258850 |
STABILIZED THERAPEUTIC COMPOSITIONS AND FORMULATIONS
The invention relates to pharmaceutically acceptable formulations comprising an active pharmaceutical ingredient such as androst-5-ene-3β,17β-diol, androst-5-ene-3β,7β,17β-triol or derivatives...
|
|
|
US20090258847 |
Cholanic Acid Amides
4-(3-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phena
nthren-17-yl)-pentanoic acid amides wherein the nitrogen of the amide group is substituted by a sulfonylaminocarbonyl-(C 1-4 )-alkyl...
|
|
|
US20090258040 |
STEROID TREATMENT FOR HOT FLASHES
Embodiments of the invention relate to methods for treating individuals suffering from hot flashes by vomeronasally administering a therapeutically effective dosage of a steroid agent. The hot...
|
|
|
US20090247497 |
FORMULATION AND USE OF ERGOSTA-7,22-DIEN-3BETA-OL
An isolated and purified form of ergosta-7,22-dien-3β-ol and its use as a marker for identifying Coriolus versicolor (Yunzhi) are provided. A composition used for treatment of cancer and other...
|
|
|
US20090247496 |
PHARMACEUTICAL COMPOSITION AND EXTRACT OF PORIA FOR ENHANCING UPTAKE OF NUTRIENTS
The present invention discloses a novel use of a lanostane having the following formula (I) in enhancing uptake of nutrients:
wherein R 1 is either H or CH 3 ; R 2 is OCOCH 3 , ═O or OH; R 3...
|
|
|
US20090239837 |
CHOLESTEROL-PRODUCING YEAST STRAINS AND USES THEREOF
The invention concerns the production of cholesterol in organisms of the Fungi kingdom. More particularly, the invention concerns genetically modified Fungus independently producing cholesterol...
|
|
|
US20090232897 |
PHARMACEUTICAL COMPOSITIONS COMPRISING CONJUGATED ESTROGENS
Pre-mix compositions containing conjugated estrogens and a pharmaceutical carrier, and pharmaceutical formulations containing a pre-mix composition. Further, the invention includes processes for...
|
|
|
US20090232865 |
End-Capped Poly(Ester Amide) Copolymers
This invention relates to poly(ester amide)s (PEAs) comprising inactivated terminal amino and carboxyl groups, methods of synthesizing the inactivated PEAs and uses for them in the treatment of...
|
|
|
US20090227552 |
FULVESTRANT FORMULATIONS
The present invention relates to novel fulvestrant formulations comprising one or more of a propylene glycol or a pharmaceutically acceptable polyethylene glycol.
|
|
|
US20090227549 |
Fulvestrant formulations
Fulvestrant formulations suitable for intramuscular injection at concentration in excess of 40 mg/ml in the absence of castor oil and castor oil derivatives are disclosed.
|
|
|
US20090226431 |
Treatment of Cancer and Other Diseases
The present invention relates to a novel compound (e.g., 24-ethyl-cholestane-3β,5α,6α-triol), its production, its use, and to methods of treating neoplasms and other tumors as well as other...
|
|
|
US20090221540 |
Method of Treating An Acute Vascular Disorder
The invention relates to a method of treating an acute vascular disorder in a mammal. The method comprises orally administering to the mammal an effective amount of a steroid. The steroid is...
|
|
|
US20090220616 |
MOISTURIZING AND LUBRICATING COMPOSITIONS
The present invention is generally directed to moisturizing and lubricating compositions for use on the bodyfacing surface of an absorbent product or on one or both faces of a tissue product. The...
|
|
|
US20090220562 |
Osteogenic and anti-adipogenic oxysterols
The present invention discloses osteogenic and anti-adipogenic oxysterols. Agents and methods for protecting, blocking or rescuing marrow stromal cells from the inhibitory effects of oxidative...
|
|
|
US20090216317 |
Delivery of Highly Lipophilic Agents Via Medical Devices
An apparatus and system for delivering a lipophilic agent associated with a medical device including: a medical device, a first lipophilic agent capable of penetrating a body lumen, wherein the...
|
|
|
US20090203658 |
NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR
Provided are methods for ameliorating a symptom of a neuropsychiatric disorder in a subject. Also provided are methods for ameliorating at least one physical symptom or at least one psychological...
|
|
|
US20090202660 |
Agents and Methods for Osteogenic Oxysterols Inhibition of Oxidative Stress on Osteogenic Cellular Differentiation
The present invention discloses oxygenic oxygenic oxysterols. Also disclosed, agents and methods for protecting, blocking or rescuing marrow stromal cells from the inhibitory effects of oxidative...
|
|
|
US20090197851 |
THERAPY AND USE OF COMPOUNDS IN THERAPY
A method of treating, preventing or ameliorating chronic heart failure or acute heart failure in a patient the method comprising administering to the patient an effective amount of: a compound that...
|
|
|
US20090197842 |
Therapeutic Agent for Neuropathic Pain
The present invention provides a therapeutic agent for neuropathic pain having an excellent treating effect on neuropathic pain, which is an intractable disorder. More specifically, the present...
|
|
|
US20090181936 |
Diene and Triene Compounds and Formulations
The instant invention provides potent antiandrogen compounds, such as 3β-acetoxyandrost-1,5-diene-17-ethylene ketal and 3β-hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in...
|
|
|
US20090181904 |
METHOD FOR REGULATING NUTRIENT ABSORPTION WITH GINSENOSIDES
The present application relates to a method of regulating nutrient absorption in a subject in need thereof with an isolated ginsenoside compound.
|
|
|
US20090181061 |
Microbial Resistant Composites
Microbial resistant composites and methods for providing microbial resistant composites are described herein. The microbial resistant composites may include a polymeric material in the form of a...
|
|
|
US20090176753 |
Betulinol derivatives as anti-cancer agents
The present invention relates to a method of treating cancer selected from the group of cancers consisting of prostate cancer, renal cancer, breast cancer, ovarian cancer, CNS cancer, melanoma,...
|
|
|
US20090176752 |
Diene Compounds and Formulations
The instant invention provides potent antiandrogen compounds, such as 3β-acetoxyandrost-1,5-diene-17-ethylene ketal and 3β-hydroxyandrost-1,5-diene-17-ethylene ketal, and methods for their use in...
|
|
|
US20090175845 |
METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE PHB DOMAIN PROTEIN ACTIVITY AND COMPOSITIONS THEREOF
The invention relates to the finding that PHB domain polypeptides can bind cholesterol and related compounds and are involved in the regulation of various cellular activities. Accordingly, the...
|
|
|
US20090163460 |
DIAGNOSTICS AND THERAPEUTICS FOR EARLY-ONSET MENOPAUSE
A method of predicting whether a subject is predisposed to developing early-onset menopause is provided. The method involves genotyping a patient at the IL-1 gene loci.
|
|
|
US20090163459 |
Use of 24-nor-UDCA
The present invention relates to the use of nor-ursodeoxycholic acid for the manufacture of a drug for the treatment and/or the prevention of liver diseases, preferably chronic liver diseases.
|
|
|
US20090163458 |
Compositions and methods for treating Parkinson's disease and related disorders
The present disclosure relates generally to methods and compositions for treating symptoms of Parkinson's disease and/or other movement disorders. More particularly, the present disclosure...
|
|
|
US20090149429 |
ANTIVIRAL COMPOUNDS
The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection.
|
|
|
US20090143349 |
STEROID TETROL SOLID STATE FORMS
The invention relates to solid state forms of androst-5-ene-3β,7β,16α,17β-triol, formulations containing or prepared from such solid state forms and use of such materials for modulating acute...
|
|
|
US20090143347 |
Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases
The invention relates to the therapeutic use of pregnenolone derivatives for treating depressive disorders and long-term neurological diseases.
|
|
|
US20090142390 |
TRANSDERMAL SYSTEMS CONTAINING MULTILAYER ADHESIVE MATRICES TO MODIFY DRUG DELIVERY
A transdermal drug-containing dosage unit comprises: a backing layer substantially impervious to the drug to be delivered transdermally; a first polymeric adhesive matrix, in contact with the...
|
|
|
US20090137544 |
Formation and rejuvenation of organs and alcohol damaged organ regeneration through stem cell nutrients
Mechanisms nourish stem cells for organ regeneration and prevent alcohol related diseases such as Fetal Alcohol Syndrome (FAS) and Liver Sclerosis. These stem cell nutrients have been found to...
|
|
|
US20090137538 |
METHOD OF TREATING ATROPHIC VAGINITIS
This invention relates to a method and pharmaceutical composition useful in treating a condition responsive to hormone replacement therapy. Specifically, the invention is related to the long term...
|
|
|
US20090131389 |
Preparation of a Crystalline Antibiotic Substance
The present invention relates to processes for the crystallisation and for the preparation and isolation of a novel crystalline form of fusidic acid, to the use of said processes in the manufacture...
|